Book an appointment with us, or search the directory to find the right lawyer for you directly through the app.
Find out more
Deal by Design
Welcome to this edition of Law Update, focusing on the evolving M&A landscape across the MENA region. With deal activity and value continuing to grow, the region is seeing increased investor interest alongside a changing regulatory environment.
This edition explores key legal and market developments affecting M&A transactions, including regulatory reforms, foreign investment, governance, due diligence and deal structuring across the region.
Healthcare facilities, laboratories and other institutions operating in the Dubai healthcare sector will be pleased to note the issuance of Decision No. 17 of 2020 (amending the previous Decision 21/8 of 2020) (the “Decision”) that will further suspend any legal proceedings issued against certain named entities for a period of six months.
The Decision applies to companies and institutions operating in the health sector and their subsidiary companies that provide services to treat people infected with Coronavirus, that have been identified by the Ministry of Health and Prevention as falling under the remit of the Decision.
The Decision confirms the:
This Decision shall take effect from the date of its issuance and for a period of six months. The date of issuance will commence from the date that the Decision is published in the Official Gazette. We expect this to be within the next 28 days.
Andrea Tithecott
Partner, Head of Regulatory, Head of Healthcare
a.tithecott@tamimi.com
To learn more about our services and get the latest legal insights from across the Middle East and North Africa region, click on the link below.